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 Abstract
Pleomorphic rhabdomyosarcoma of the uterus is a rare malignant tumor. It is connected with postmenopausal 
abnormal vaginal bleeding and abdominal pain. 
We report a case of a 66-year-old postmenopausal woman diagnosed with abnormal vaginal bleeding and 
abdominal pain. Vaginal ultrasonography showed enlarged uterus, 82mm x 64mm in size. The patient underwent 
total abdominal hysterectomy and bilateral salpingo-oophorectomy with postoperative chemotherapy due to 
pleomorphic rhabdomyosarcoma of the uterus. The patient died 2,5 years after the surgery as a result of a rapid 
spread of the neoplastic process. The case of rhabdomyosarcoma, together with the review of the literature, is 
presented in the following work. We find that the rarity of this histological entity makes it particularly worthy of 
publication.
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 Streszczenie
Mięsak pleomorficzny, prążkowanokomórkowy jest rzadkim nienabłonkowym nowotworem złośliwym mięśnia 
macicy, występującym u pomenopauzalnych pacjentek, które zgłaszają w wywiadzie nieprawidłowe krwawienia 
maciczne i dolegliwości bólowe podbrzusza. 
W opisywanej sytuacji klinicznej 66 letnia wieloródka była hospitalizowana z powodu nieprawidłowego 
krwawienia z dróg rodnych oraz bólu podbrzusza. W badaniu USG uwidoczniono powiększony trzon macicy 
o wymiarach 82x64 mm. Przeprowadzono zabieg usunięcia macicy z przydatkami w sposób typowy. W badaniu 
histopatologicznym, potwierdzonym immunohistochemiczne, stwierdzono postać pleomorficzną mięsaka trzonu 
macicy. Po operacji pacjentka przeszła chemioterapię. Z powodu przerzutów pacjentka zmarła po około 2,5 
roku od leczenia chirurgicznego. Z powodu bardzo rzadkiego występowania postaci pleomorficznej mięsaka 
prążkowanokomórkowego macicy, ten opis przypadku, łącznie z przeglądem literatury, wart jest opublikowania.
 Słowa kluczowe: postać pleomorficzna / mięsak prążkowanokomórkowy / macica /  
     / menopauza, / krwawienie / mięsak / dorośli  / 
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Introduction
Sarcomas	 of	 the	 uterine	 corpus	 are	 rare,	 non-epithelial	
malignant	 tumors	which	 constitute	 2%	 to	 5%	of	 all	malignant	
uterine	 tumors	 [1].	 Incidence	 rate	 is	 from	 0,5	 to	 2/100	 000	 of	
women	 [2].	 The	 most	 common	 types	 are:	 mixed	 mesodermal	
tumors,	 leiomyosarcomas,	 and	 endometrial	 stromal	 tumors.	
Other	 histological	 types,	 including	 e.g.	 rhabdomyosarcomas,	
liposarcomas,	 chondrosarcomas	 have	 very	 low	 incidence	 [3].	
Rhabdomyosarcoma	 is	 a	 tumor	 with	 a	 very	 high	 degree	 of	
histological	malignancy	and	is	extremely	rare	in	the	uterine	corpus.	
Three	general	pathologic	types	of	rhabdomyosarcoma:	embryonal,	
alveolar,	and	pleomorphic,	have	been	described	in	literature	[3,4].	
Unfortunately,	uterine	pleomorphic	rhabdomyosarcomas	are	rare	
and	highly	malignant	tumors,	with	frequent	extrauterine	spread	at	
presentation	which	makes	it	difficult	to	study	the	cases.	Patients	
rarely	survive	longer	than	15	months	[5].
We	 present	 a	 case	 of	 a	 66-year-old	 woman	 with	
postmenopausal	vaginal	bleeding	and	abdominal	pain	caused	by	
pleomorphic	rhabdomyosarcoma	of	the	corpus	uteri.	
Case	report
A	66-year-old	multipara	was	admitted	to	clinical	hospital	of	
Poznań	University	of	Medical	Sciences	in	2004	due	to	abnormal	
vaginal	bleeding	and	abdominal	pain.	
Gynecological	examination	showed	anteflexed	and	enlarged	
uterine	 corpus.	 Ultrasonography	 revealed	 uterine	 corpus	 to	 be	
82mm	x	64mm	in	dimension	and	52mm	thick,	with	fluid-filled	
endometrium	constituting	2/3	of	the	uterine	wall.	In	the	interview	
the	patient	reported	last	menstruation	at	the	age	of	48	and	a	few	
years	of	hypertension	therapy	with	Enarenal	(10mg	twice	a	day),	
Staveran	and	Lorafen	(80mg	and	2.5mg	once	a	day,	respectively).	
Obesity	(BMI=39.5),	gout	and	condition	after	cholecystectomy,	
performed	 in	 1983	 due	 to	 cholecystolithiasis,	 were	 found	 as	
well.	 Chest	 RTG	 showed	 aorta	 atherosclerosis.	 Dilation	 and	
curettage	of	 the	uterus	were	proposed	due	 to	 clinical	 state	 and	
after	gynecological	examination.	However,	when	the	patient	was	
under	general	anesthesia,	the	dilatation	of	external	orifice	of	the	
uterus	proved	to	be	impossible.	The	procedure	of	curettage	of	the	
uterus	cavity	was	aborted	and	hysterectomy	with	adnexectomy	
was	 performed	 instead.	 Laparotomy	 disclosed	 enlarged	 soft	
uterus,	6	x	7cm	in	dimension,	which	was	then	removed	together	
with	adnexa	in	a	typical	manner.	In	palpation	examination	of	the	
liver,	greater	omentum	and	parietal	peritoneum	of	pelvis	minor	
no	metastases	were	found.	The	patient	was	discharged	home	in	
overall	good	condition,	without	any	ailments.	
The	result	of	the	histopathological	examination	obtained	after	
14	 days	 stated:	 ‘Rhabdomyosarcoma	 pleomorphicum	 corporis	
uteri	 partim	 necroticum	 at	 haemorrhagicum.	 Endometrium	
atrophicum.	 Leiomyomata	 parva	 corporis	 uteri.	 Endocervicitis	
chronica.	 Erosio	 glandularis	 in	 statu	 epidermisationis.	 Fibrosis	
adnexorum’.	 Immunohistochemical	 analyses	 (Myf	 4+,	
actin+,	 desmin+,	 vimentin+)	 that	 confirmed	 the	 diagnosis	 of	
pleomorphic	 rhabdomyosarcoma	 were	 carried	 out.	 Six	 cycles	
of	 postoperative	 chemotherapy	 (with	 500	 mg/m2 intravenous	
(IV)	 Cyclophosphamide/1day,	 1mg/m2  IV	 Vincristine/1	 and	 5	
day,	50mg/m2  IV	Doxorubicin/1day,	250mg/m2  IV	Dacarbazine	
1	 and	 5	 day)	 were	 given	 according	 to	 protocol.	 Follow-up	
examinations	 one	 year	 after	 surgery	 revealed	 no	 abnormalities	
or	tumor	recurrence.	Eighteen	months	after	the	surgery	FUSION	
PET	(PET/CT)	of	facial	skeleton,	neck,	chest,	abdominal	cavity	
and	 pelvis	 was	 performed	 and	 no	 foci	 of	 increased	 glucose	
metabolism	 corresponding	 to	 active	 proliferative	 process	 were	
observed.	 Unfortunately,	 the	 patient	 died	 2.5	 years	 after	 the	
surgery	due	to	rapid	spread	of	neoplastic,	intraperitoneal	process	
and	metastases	to	the	lung	and	liver.	
Discussion
Sarcomas	 account	 for	 <5%	 of	 endometrial	 curettage.	
The	 most	 common	 types,	 over	 95%	 of	 all	 uterine	 sarcomas,	
include	 mixed	 mesodermal	 tumors,	 leiomyosarcomas	 and	
endometrial	 stromal	 tumors.	 Other	 histological	 types,	 e.g.	
rhabdomyosarcomas,	 liposarcomas	 and	 chondrosarcomas,	
have	 very	 low	 incidence	 (0.05/100	 000	 women)	 [3].	 Three	
general	pathologic	types	of	rhabdomyosarcoma,	i.e.	embryonal,	
alveolar,	 and	 pleomorphic,	 have	 been	 described	 in	 literature	
[4].		Embryonal	and	alveolar	rhabdomyosarcomas	occur	in	girls	
and	young	women,	whereas	pleomorphic	rhabdomyosarcoma	is	
diagnosed	in	elderly,	postmenopausal	patients,	usually	above	age	
45	[2,	3].	Pleomorphic	rhabdomyosarcoma	has	very	high	degree	
of	histological	malignancy	and	 is	 extremely	 rare	 in	 the	uterine	
corpus.
Risk	factors	are	similar	to	those	of	endometrial	carcinoma.	
The	 most	 frequent	 symptom,	 reported	 by	 80%	 of	 patients,	 is	
abnormal	vaginal	bleeding	[2,	3].	The	bleeding	is	accompanied	
by	 abdominal	 pain	 resulting	 from	 uterine	 contractions	 and	
removal	 of	 fragments	 of	 neoplastic	 tissues	 from	 the	 genital	
tract	 [2,3].	 Gynecological	 examinations	 reveal	 enlarged	 uterus	
and	 palpable	 tumor	 in	 pelvis	minor	 in	 20-40%	of	 patients	 [3].	
Ultrasound	diagnostic	of	endometrial	thickness	is	also	usefulness	
tool	 in	 diagnosis	 of	 endometrium	 pathology	 in	 patients	 with	
abnormal	postmenopausal	vaginal	bleeding	[6].	In	the	described	
clinical	 case	 the	 66-year-old	 patient	 was	 hospitalized	 due	 to	
abnormal	postmenopausal	vaginal	bleeding	and	abdominal	pain,	
i.e.	symptoms	of	low	specificity.
Histopathological	 analysis	 of	 the	 material	 from	 curettage	
of	the	uterus	is	the	basis	of	preliminary	diagnosis	of	neoplastic	
changes.	Final	diagnosis	of	 the	degree	and	extent	of	neoplastic	
process	is	based	on	the	results	of	histopathological	analysis	of	the	
tissue	sampled	during	operation	(among	others,	preparation	of	the	
uterus	with	adnexa	and	greater	omentum	and	lymph	nodes	biopsy).	
In	case	of	our	patient,	the	dilatation	of	external	orifice	of	the	uterus	
was	 impossible	 and	 the	 procedure	 of	 curettage	 of	 the	 uterine	
cavity	was	aborted.	The	surgery	included	only	hysterectomy	with	
adnexectomy	as	the	pleomorphic	rhabdomyosarcoma	of	uterine	
corpus	 was	 diagnosed	 only	 after	 histopathological	 analysis	 of	
operational	 material	 and	 immunohistochemical	 examination	
confirming	the	diagnosis	were	performed.	
Open-access	 medical	 data	 bases	 include	 few	 cases	 of	
pleomorphic	 rhabdomyosarcomas	 of	 the	 uterine	 corpus.	
Observations	of	Norddal	and	Thoresen	[7]	carried	out	from	1956	
to	1992	in	a	group	of	1042	women	diagnosed	with	and	treated	
for	sarcomas	of	the	uterine	corpus,	showed	that	only	11	patients	
suffered	from	pleomorphic	rhabdomyosarcoma	[7].	Similarly,	in	
studies	lasting	27	years	(since	1974	to	2001)	conducted	by	Livi	et	
al.	in	a	group	of	141	women	only	one	case	of	rhabdomyosarcoma	
was	 confirmed	 in	 histopathological	 examination	 [8].	 Hart	 et	
al.	 described	 two	 botryoid	 embryonal	 and	 two	 pleomorphic	
rhabdomyosarcomas	in	adult	patients	[9].	
©  P o l s k i e  T o w a r z y s t w o  G i n e k o l o g i c z n e 543
P R A C E  K A Z U I S T Y C Z N E
  g in eko l og ia 
Ginekol Pol. 2010, 81, 541-543 
Pleomorphic rhabdomyosarcoma of the uterine corpus...
Both	 patients,	 with	 typical	 botryoid	 embryonal	
rhabdomyosarcomas	 were	 alive	 and	well,	 following	 combined	
treatments	 with	 surgery	 and	 chemotherapy	 or	 irradiation,	 3.0	
and	 2.7	 years	 after	 the	 operation.	The	 other	 two	women,	with	
pleomorphic	 rhabdomyosarcomas,	 died	 rapidly	 of	 widespread	
tumor	 [9].	 In	 another	 study	Borka	 et	 al.	 described	 a	 case	 of	 a	
67-year-old	 woman	 with	 postmenopausal	 vaginal	 bleeding	
caused	by	pleomorphic	rhabdomyosarcoma	of	the	uterus,	treated	
with	laparotomy	and	postoperative	chemotherapy	[10].	
Pleomorphic	 rhabdomyosarcoma	 of	 the	 uterine	 corpus	
is	 a	 sarcoma	 of	 high	 degree	 of	 histological	 malignancy.	 It	
consists	of	multiform,	sometimes	 fusiform,	big	and	often	 large	
multinuclear	 neoplastic	 cells	 with	 acidophilic	 cytoplasm.	
Neoplastic	cells	are	chaotically	distributed	 in	connective	 tissue	
stroma	and	the	transverse	striation	is	almost	never	observed	[2].	
Immunohistochemical	 analysis	 is	 an	 essential	 tool	 verifying	
histological	types	of	rhabdomyosarcomas.	However,	expression	
of	desmin	and	muscle	actin	is	noticeable	[2].	
Treatment	of	uterine	sarcoma	relies	on	precise	diagnosis	of	
its	 histological	 form	 and	 clinical	 evaluation	 of	 its	 progression.	
Resulting	 chemotherapy	 is	 based	 mostly	 on	 antracyclins	 and	
ifosfamide	 [11].	Adjuvant	 chemotherapy	with	VAC	 (vincristin,	
actinomycin	 D	 and	 cyclophosphamide)	 may	 also	 improve	
survival	 [12].	 Yeasmin	 et	 al	 described	 a	 case	 of	 a	 60-year-
old	 postmenopausal	 woman	 diagnosed	 with	 pleomorphic	
rhabdomyosarcoma.	After	 surgery	 and	 systemic	 chemotherapy	
and	pelvic	irradiation	with	a	high	lactate	dehydrogenase	(LDH)	
level,	 the	 patient	 died	within	 20	months	 of	 the	 diagnosis	 [13].	
Borka	 et	 al	 published	 a	 case	 of	 a	 67-year-old	 woman	 who	
underwent	laparotomy	and	postoperative	chemotherapy	to	survive	
one	year	after	the	surgery	[10].	While	radiotherapy	reduces	the	
frequency	of	recurrence,	its	impact	on	a	5-year	survival	has	not	
been	proven	 [2].	However,	 there	 is	 evidence	 that	patients	with	
embryonal	 and	 alveolar	 rhabdomyosarcomas	 live	 long	 enough	
for	the	effect	of	multicomponent	therapy	on	occurrence	of	other	
tumors	to	be	accessible.	These	are	usually	osteosarcoma	(caused	
by	 radiotherapy)	 or	 non-lymphatic	 leukemia	 (complication	 of	
chemotherapy)	 and	 the	 risk	 of	 their	 appearance	 is	 1.7%	 in	 the	
course	of	10	years	[2].	It	seems	that	combined	therapy	(surgery	
with	chemo	and	radiotherapy)	has	resulted	in	long-term	survival	
for	 majority	 of	 patients	 with	 urogenital	 rhabdomyosarcomas	
[10].
Pleomorphic	variant	rhabdomyosarcomas	are	very	aggressive	
neoplasms	with	extremely	poor	prognosis.	Almost	2-year	survival	
of	our	patient	after	surgery	with	no	detection	of	any	recurrences	
may	be	considered	a	success.	
Conclusions
Summing	 up,	 the	 above-described	 clinical	 case	 of	
pleomorphic	rhabdomyosarcoma	of	the	uterine	corpus	is	a	very	
rare	malignant	tumor.	Its	diagnosis	is	based	on	histopathological	
analysis	 confirmed	 by	 immunohistochemical	 examination	 and	
clinical	symptoms	are	non-specific.	The	rarity	of	this	histological	
entity	and	protocol	 applied	make	 the	presented	case	worthy	of	
publication.
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